Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14612757 | 0.81 | CYP2A6 (0.44) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL15948913 | 0.81 | ALDH1A1 (0.44) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL12807315 | 0.80 | HSD17B10 (0.48) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL13209682 | 0.77 | POLB (0.50) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL1556905 | 0.75 | CYP1A2 (0.58) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL24562319 | 0.68 | ALDH1A1 (0.52) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL8363259 | 0.68 | PTPN22 (0.60) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL9071601 | 0.68 | CYP2A6 (0.60) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| Phenanthrene SCHEMBL7643 | 0.66 | CYP2A6 (1.00) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 | |
| Phenanthrene SCHEMBL29477074 | 0.66 | CYP2A6 (1.00) | HSD17B10ALDH1A1CYP2A6TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110301310-A1 | Pyridyldiamido Transition Metal Complexes, Production And Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301310-A1 | Pyridyldiamido Transition Metal Complexes, Production And Use Thereof | PNPO, PLPBP, PDXK | HSD17B10 3127/4885ALDH1A1 1554/4885CYP2A6 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.